Different subtypes of ultrasound‐diagnosed adenomyosis and in vitro fertilization outcomes: A systematic review and meta‐analysis

Author:

Wang Xia‐Li12,Xu Zi‐Wei1,Huang Yan‐Yan1,Lin Shu34,Lyu Guo‐Rong12ORCID

Affiliation:

1. Department of Ultrasound Second Affiliated Hospital of Fujian Medical University Quanzhou China

2. Department of Clinical Medicine Quanzhou Medical College Quanzhou China

3. Center of Neurological and Metabolic Research Second Affiliated Hospital of Fujian Medical University Quanzhou China

4. Diabetes and Metabolism Division Garvan Institute of Medical Research Darlinghurst Sydney Australia

Abstract

AbstractIntroductionAdenomyosis prevalence among women with infertility is increasing; their management during in vitro fertilization is usually based on ultrasound diagnosis alone. Herein, we summarize the latest evidence on the impact of ultrasound‐diagnosed adenomyosis on in vitro fertilization outcomes.Material and methodsThe study was registered with The International Prospective Register of Systematic Reviews (CRD42022355584). We searched PubMed, Embase, and Cochrane Library databases from inception to January 31, 2023, for cohort studies on the impact of adenomyosis on in vitro fertilization outcomes. Fertility outcomes were compared according to the presence of adenomyosis as diagnosed by ultrasound, concurrent endometriosis and adenomyosis, and MRI‐based or MRI‐ and ultrasound‐based adenomyosis diagnosis. Live birth rate was the primary outcome while clinical pregnancy and miscarriage rates were secondary outcomes.ResultsWomen diagnosed with adenomyosis by ultrasound had lower live birth (odds ratio [OR] = 0.66; 95% confidence interval [CI]: 0.53–0.82, grade: very low), lower clinical pregnancy (OR = 0.64; 95% CI: 0.53–0.77, grade: very low), and higher miscarriage (OR = 1.81; 95% CI: 1.35–2.44, grade: very low) rates than those without adenomyosis. Notably, symptomatic and diffuse, but not asymptomatic adenomyosis as diagnosed by ultrasound, adversely affected in vitro fertilization outcomes, with lower live birth (OR = 0.57; 95% CI: 0.34–0.96, grade: very low), clinical pregnancy (OR = 0.69; 95% CI: 0.57–0.85, grade: low), and miscarriage (OR = 2.48, 95% CI: 1.28–4.82, grade: low) rates; and lower live birth (OR = 0.37; 95% CI: 0.23–0.59, grade: low) and clinical pregnancy (OR = 0.50; 95% CI: 0.34–0.75, grade: low), but not miscarriage rate (OR = 2.18; 95% CI: 0.72–6.62, grade: very low), respectively. Concurrent adenomyosis in endometriosis is associated with a significantly lower live birth rate (OR = 0.44; 95% CI: 0.26–0.75, grade: low) than endometriosis alone. Finally, the use of MRI‐based or MRI‐ and ultrasound‐based adenomyosis diagnosis showed no significant association with in vitro fertilization outcomes (grade: very low for all outcomes).ConclusionsConsidering ultrasound findings, symptoms, and different subtypes of adenomyosis may aid in offering personalized counseling, improving treatment decisions, and achieving better outcomes of in vitro fertilization.

Publisher

Wiley

Subject

Obstetrics and Gynecology,General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3